The 17 analysts offering 1 year price forecasts for GSK1/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 23 analysts giving stock ratings to GSK1/N in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GSK1/N EPS for the last quarter is 13.09 MXN despite the estimation of 11.56 MXN. In the next quarter EPS is expected to reach 4.93 MXN. Track more of GSK PLC financials and stay on top of what is up with the company.
In the next quarter GSK PLC revenue is expected to reach 194.46 B MXN. Check out GSK PLC revenue and earnings and make informed decisions.
According to analysts, GSK1/N price target is 420.90 MXN with a max estimate of 626.48 MXN and a min estimate of 300.61 MXN. Check if this forecast comes true in a year, meanwhile watch GSK PLC stock price chart and keep track of the current situation with GSK1/N news and stock market news.
We've gathered opinions of 23 analysts rating GSK1/N stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.